<DOC>
	<DOCNO>NCT02244216</DOCNO>
	<brief_summary>Study obtain data change chlorofluorocarbon ( CFC ) - contain Berotec® 200 µg meter - dose inhaler CFC - free Berotec® N 100 µg meter - dose inhaler</brief_summary>
	<brief_title>Postmarketing Surveillance Study Berotec® N 100 µg Metered-dose Inhaler Chronic Obstructive Respiratory Tract Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Fenoterol</mesh_term>
	<criteria>Patients include study treat Berotec® 200 µg meter dose inhaler switch CFCfree Berotec® N 100 µg meter dose inhaler • Contraindications list Instructions Use/Summary Product Characteristics Berotec® N 100 µg meter dose inhaler</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>